SAIGON PHARMA
Saigon Pharma, officially known as Saigon Pharmaceutical Company, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 1975, the company has made significant strides in the production and distribution of high-quality pharmaceutical products across various regions, including Southeast Asia and beyond. Specialising in generic medicines, Saigon Pharma offers a diverse range of products, including tablets, capsules, and injectables, all designed to meet stringent quality standards. The company is recognised for its commitment to innovation and has achieved notable milestones, such as obtaining international certifications that enhance its market position. With a strong focus on research and development, Saigon Pharma continues to expand its portfolio, ensuring that it meets the evolving needs of healthcare providers and patients alike. Its dedication to quality and accessibility has solidified its reputation as a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does SAIGON PHARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SAIGON PHARMA's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SAIGON PHARMA's reported carbon emissions
SAIGON PHARMA, headquartered in Vietnam, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. Additionally, the company has not outlined any formal reduction targets or climate pledges, which limits the ability to assess their commitments towards mitigating climate change. In the absence of specific emissions data and reduction initiatives, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and carbon footprint reduction. This trend often includes setting science-based targets and engaging in various environmental initiatives to align with global climate goals. As SAIGON PHARMA continues to navigate the evolving landscape of corporate responsibility, future commitments and data disclosures will be crucial for understanding their impact on climate change and their role in promoting sustainability within the industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SAIGON PHARMA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
